SHL TelemedicineSHMLF 51 Days Payable is 45.48 as of Dec. 2025, which is 53% above its 10-year median of 29.67. GuruFocus rates SHMLF with a GF Score™ of 51/100 and a GF Value™ of $13.95. The stock has 3 warning signs investors should review. Among 608 Healthcare Providers & Services companies, SHL Telemedicine ranks worse than 59.05% on this metric.
The historical rank and industry rank for SHL Telemedicine's Days Payable or its related term are showing as below:
SHMLF'
s Days Payable Range Over the Past 10 Years
Min: 19.88 Med: 29.67 Max: 51.36
Current: 47.37
During the past 13 years, SHL Telemedicine's highest Days Payable was 51.36. The lowest was 19.88. And the median was 29.67.
SHMLF's Days Payable is ranked worse than 59.05% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs SHMLF: 47.37
SHL Telemedicine's Days Payable
increased
from Dec. 2024 (40.24) to Dec. 2025 (45.48).
It may suggest that SHL Telemedicinedelayed paying its suppliers.
SHL Telemedicine Days Payable Related Terms
SHL Telemedicine Days Payable Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, SHL Telemedicine's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Days Payable distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SHL Telemedicine's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (SHMLF) has a Days Payable of 45.48 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SHL Telemedicine and its competitors. This is 53% above median its historical median of 29.67. Over the past decade, SHL Telemedicine's Days Payable has ranged from 19.88 to 51.36. According to the industry distribution chart, SHL Telemedicine ranks #359 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 59%.
Is SHL Telemedicine's Days Payable too high?
SHL Telemedicine's current Days Payable of 45.48 is 53% above median its 10-year median of 29.67. Over the past 10 years, this metric has ranged from a low of 19.88 to a high of 51.36. The Healthcare Providers & Services industry median Days Payable is 58.08. SHL Telemedicine's value of 45.48 is 21.7% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #359 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, SHL Telemedicine has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #359 out of 608 companies for Days Payable. This places SHL Telemedicine in the lower half of its industry. The industry median Days Payable is 58.08. SHL Telemedicine's value of 45.48 is 21.7% below this benchmark. Historically, SHL Telemedicine's own Days Payable has ranged from 19.88 to 51.36 over the past decade. While the company's 10-year median is 29.67 vs. the industry median of 58.08, SHL Telemedicine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Days Payable of 45.48 is 21.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Days Payable is 45.48, which is 53% above median its own 10-year median of 29.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Days Payable of 45.48. The stock's GF Value™ is $13.95, compared to a current price of $4.84 — trading 65.3% below its estimated fair value. The current Days Payable is 45.48, which is 53% above median its 10-year median of 29.67 and 21.7% below the Healthcare Providers & Services industry median of 58.08. SHL Telemedicine's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Days Payable is 45.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (SHMLF) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of $4.84 is trading 65.3% below its estimated GF Value™ of $13.95.
Key valuation signals for SHMLF:
Days Payable: 45.48 (53% above median its 10-year median of 29.67)
GF Value™: $13.95 vs. price of $4.84 (65.3% below fair value)
Industry Position: 21.7% below the Healthcare Providers & Services median (#359 of 608)
No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
51GF Score
Get the complete analysis for SHMLF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHMLF has been successfully added to your 
